SYDNEY, Nov 17 (Reuters) - The Australian dollar climbed to a one-week high on Tuesday, holding above key chart resistance of 73 U.S. cents, while its New Zealand peer was perched at a 19-month top as investor sentiment was boosted by coronavirus vaccine hopes.
Risk assets were buoyed overnight by news that Moderna’s COVID-19 vaccine recorded a 94.5% efficacy rate in preliminary numbers from a large late-stage clinical trial.
The Australian dollar, a liquid proxy for risk, rose to $0.7319, a level last seen on Nov. 9. It was edging closer to a recent nine-week peak of $0.7340.
The New Zealand dollar was up at $0.6910. It was also within striking distance of a $0.6938 top from March 2019, a break of which would be bullish technically.
Earlier, the Reserve Bank of Australia (RBA) released minutes of its Nov 3 policy meeting in which it said it was ready to provide yet more policy stimulus if needed.
The RBA had trimmed the cash rate to 0.1% and launched a A$100 billion quantitative easing (QE) programme over six months.
Original article:
Dieditkan 17 Nov 2020, 11:15
Penafian: Pandangan yang dinyatakan adalah semata-mata dari pengarang dan tidak mewakili kedudukan rasmi Followme. Followme tidak bertanggungjawab ke atas ketepatan, kesempurnaan, atau kebolehpercayaan maklumat yang diberikan dan tidak bertanggungjawab untuk sebarang tindakan yang diambil berdasarkan kandungan, melainkan dinyatakan secara bertulis secara jelas.
Tiada komen lama, mula komen sekarang